Scalp · Photobiomodulation

LED Scalp Therapy

How this page was made
This page was written with AI assistance and reviewed against the sources listed under References below. It is general information only, not medical advice. See our full disclaimer for how SHEA creates and reviews treatment information.
01

What it is

LED scalp therapy exposes the scalp to low-intensity light from light-emitting diodes. It belongs to the broader field of photobiomodulation, also called low-level light therapy (LLLT).

Photobiomodulation devices used for hair can contain LEDs, laser diodes, or a combination of both. Red light around the mid-600 nm range is common in published hair-growth research, although devices vary considerably in wavelength, irradiance, total dose, treatment schedule and the way light reaches the scalp.

The exact biological mechanisms are still being investigated. Proposed mechanisms include effects on mitochondrial signalling, cellular metabolism and pathways involved in inflammation and the hair-growth cycle. A plausible mechanism does not establish that every LED device produces a clinically meaningful effect.

The device matters
Evidence for photobiomodulation cannot automatically be transferred from one light device to another. Wavelength, irradiance, dose, treatment schedule, light source, device geometry and scalp coverage can all differ. A general salon LED panel should not be assumed to perform like a specific device tested in a clinical trial.
02

Why people consider it

  • Interest in photobiomodulation as a non-invasive approach studied for pattern hair loss
  • As an additional step alongside other hair or scalp treatments
  • Because some scalp-care and head-spa programs include red-light treatment as part of a larger session
03

What the experience is like

A hood, panel, cap, helmet or handheld light device is positioned over or close to the scalp. The treatment itself is non-invasive, and the light may be continuous or pulsed depending on the device.

Session length and treatment frequency depend on the device and protocol. Hair-growth studies generally evaluate repeated treatment over weeks or months rather than a single exposure.

Some devices require eye protection or other precautions. The instructions for the specific equipment being used should be followed.

04

Limitations & considerations

  • There is human clinical evidence supporting low-level light and laser therapy for androgenetic alopecia, but this does not establish that every LED scalp device or salon protocol is effective
  • Published studies have used different combinations of LEDs and lasers, wavelengths, doses, device designs and treatment schedules. Results from one device should not automatically be transferred to another
  • Some randomized hair-growth trials used devices containing both laser diodes and LEDs. These studies therefore cannot determine how much of the observed effect came from the LED component alone
  • The evidence is strongest for androgenetic alopecia. Evidence for other types of hair loss is considerably more limited
  • Photobiomodulation research generally involves repeated treatment. Evidence from multi-week protocols does not establish a hair-growth benefit from occasional LED exposure during a scalp-care session
  • Claims about reduced inflammation, improved follicle function or other biological effects should be distinguished from demonstrated clinical outcomes such as measured hair density
  • Significant or unexplained hair loss may require medical assessment to determine the underlying cause rather than relying on LED treatment alone
Evidence note
Randomized controlled trials have evaluated low-level light devices directly on the human scalp. One sham-controlled study in men with androgenetic alopecia used a helmet containing 21 red laser diodes and 30 red LEDs centered around 655 nm. Participants used the device repeatedly for 16 weeks, and the active-treatment group showed a greater increase in hair counts than the sham group. A corresponding study in women using the same general technology also reported a greater change in hair counts with active treatment.
These trials are relevant because LEDs were part of the active devices, but they do not establish the effectiveness of LED light by itself. The devices combined laser and LED sources and followed a defined repeated-treatment protocol.
A 2025 systematic review and meta-analysis included 38 studies involving 3,098 participants across several forms of alopecia. Most participants had androgenetic alopecia. The analysis found greater hair-density improvement with low-level laser/LED therapy than placebo in androgenetic alopecia, while heterogeneity between studies was high and evidence for other alopecia types was much more limited.
Hamblin's 2019 review discusses proposed mechanisms and clinical research on photobiomodulation for alopecia. The author disclosed numerous advisory, consulting and stockholding relationships involving companies in photobiomodulation and related fields. This does not invalidate the review, but it is relevant context when weighing its interpretation of the evidence.
Overall, photobiomodulation has a human clinical evidence base for androgenetic alopecia. That evidence should remain tied to the devices and repeated-treatment protocols studied rather than being generalized to any LED panel used during a scalp-care session.

References

Human clinical research and reviews on low-level light and laser therapy for hair loss. Device specifications and protocols vary between studies.

1. Lanzafame RJ, Blanche RR, Bodian AB, Chiacchierini RP, Fernandez-Obregon A, Kazmirek ER. The growth of human scalp hair mediated by visible red light laser and LED sources in males. Lasers in Surgery and Medicine. 2013;45(8):487–495.
Randomized sham-controlled trial · Men · Laser + LED device
2. Lanzafame RJ, Blanche RR, Chiacchierini RP, Kazmirek ER, Sklar JA. The growth of human scalp hair in females using visible red light laser and LED sources. Lasers in Surgery and Medicine. 2014;46(8):601–607.
Randomized sham-controlled trial · Women · Laser + LED device
3. Perez SM, Vattigunta M, Kelly C, Eber A. Low-Level Laser and LED Therapy in Alopecia: A Systematic Review and Meta-Analysis. Dermatologic Surgery. 2025;51(2):179–183.
Systematic review & meta-analysis · 38 studies · 3,098 participants
4. Hamblin MR. Photobiomodulation for the management of alopecia: mechanisms of action, patient selection and perspectives. Clinical, Cosmetic and Investigational Dermatology. 2019;12:669–678.
Peer-reviewed review · Alopecia · Extensive author industry ties disclosed
Scroll to Top